• 07/31/2008 - New England Journal of Medicine article of the results of the Phase 3  HIV effectiveness trial of cellulose sulfate
• 09/30/2007 -  Gates Foundation Give CONRAD $28.5M for Microbicide research
• 07/25/2007 - Final HIV  Result of Ushercell Trial Presented at IAS  Conference in Sydney
• 1/31/2007 - Phase III Trials of Cellulose Sulfate Microbicide for HIV Prevention Closed
• 12/11/2006 - Gilead Grants Intellectual Property Rights For Tenofovir Topical Gel To The International Partnership For Microbicides And Conrad
• 02/08/2006 - Gates Foundation And Congressman Davis Address Microbicides And Hiv Prevention For Women At National Press Club
• 02/01/2006 - New Licensing Agreement to Maximize AIDS Drug Development
• 01/26/2006 - CONRAD Announces Results of Phase II Clinical Trial for Ushercell
• 10/20/2005 - International Conference On Aids India Presents Lifetime Achievement Award

For media inquiries, please contact:
Annette Larkin, Rational PR, 202.429.4929 or annettelarkin@rationalpr.com. Mobile 703.772.6427